This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 1992 Feb 15;339(8790):436.

Pulmonary hypertension and dexfenfluramine

P G Atanassoff, B M Weiss, E R Schmid, M Tornic

PMID: 1346703

Case Reports

Pulmonary hypertension and dexfenfluramine

P G Atanassoff et al. Lancet. 1992.

. 1992 Feb 15;339(8790):436.

Authors

P G Atanassoff, B M Weiss, E R Schmid, M Tornic

PMID: 1346703

No abstract available

PubMed Disclaimer

Similar articles

[Appetite depressants and pulmonary hypertension].
Hellermann J, Salomon F. Hellermann J, et al. Ther Umsch. 1998 Sep;55(9):548-50. Ther Umsch. 1998. PMID: 9789468 German.
Pulmonary hypertension and dexfenfluramine.
Cacoub P, Dorent R, Nataf P, Houppe JP, Piette JC, Godeau P, Gandjbakhch I. Cacoub P, et al. Eur J Clin Pharmacol. 1995;48(1):81-3. doi: 10.1007/BF00202179. Eur J Clin Pharmacol. 1995. PMID: 7621854
Pulmonary hypertension and dexfenfluramine.
Roche N, Labrune S, Braun JM, Huchon GJ. Roche N, et al. Lancet. 1992 Feb 15;339(8790):436-7. Lancet. 1992. PMID: 1346704 No abstract available.
Anorexigen-related cardiopulmonary toxicity.
Gross SB, Lepor NE. Gross SB, et al. Rev Cardiovasc Med. 2000 Fall;1(2):80-9, 102. Rev Cardiovasc Med. 2000. PMID: 12457145 Review.
Pulmonary hypertension, hyperthyroidism, and fenfluramine: a case report and review.
Leung YY, Tang KS, Tsang CC, Chan CK, Wong KK, Yu AW. Leung YY, et al. MedGenMed. 2006 Nov 8;8(4):29. MedGenMed. 2006. PMID: 17415311 Free PMC article. Review.

See all similar articles

Cited by

Safety of drug therapies used for weight loss and treatment of obesity.
Ioannides-Demos LL, Proietto J, Tonkin AM, McNeil JJ. Ioannides-Demos LL, et al. Drug Saf. 2006;29(4):277-302. doi: 10.2165/00002018-200629040-00001. Drug Saf. 2006. PMID: 16569079 Review.
Dexfenfluramine. An updated review of its therapeutic use in the management of obesity.
Davis R, Faulds D. Davis R, et al. Drugs. 1996 Nov;52(5):696-724. doi: 10.2165/00003495-199652050-00007. Drugs. 1996. PMID: 9118819 Review.
Role of serotoninergic pathways in drug-induced valvular heart disease and diagnostic features by echocardiography.
Smith SA, Waggoner AD, de las Fuentes L, Davila-Roman VG. Smith SA, et al. J Am Soc Echocardiogr. 2009 Aug;22(8):883-9. doi: 10.1016/j.echo.2009.05.002. Epub 2009 Jun 23. J Am Soc Echocardiogr. 2009. PMID: 19553085 Free PMC article. Review.
Editorial: Case reports in thoracic oncology: 2022.
Perry Y. Perry Y. Front Oncol. 2024 Mar 20;14:1369799. doi: 10.3389/fonc.2024.1369799. eCollection 2024. Front Oncol. 2024. PMID: 38577335 Free PMC article. No abstract available.
Dexfenfluramine. A review of its pharmacological properties and therapeutic potential in obesity.
McTavish D, Heel RC. McTavish D, et al. Drugs. 1992 May;43(5):713-33. doi: 10.2165/00003495-199243050-00007. Drugs. 1992. PMID: 1379149 Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information